NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NAVCO Pharmaceuticals Inc. has announced the approval of its first Health Canada Natural Health Product license for an antimicrobial skin shield spray, utilizing innovative silver nanoparticle technology. Designed to protect against a wide array of pathogens and assist in treating minor skin wounds, NAVCO’s spray is alcohol-free and aims to provide a safer, more skin-friendly alternative to current market options.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.